TickerFactsScreenerDevelopers

Cocrystal Pharma, Inc. (COCP) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2010: $357.6K2011: $575.4K2012: $152.1K2013: $4.0K2014: $5.0K2015: $339.0K2016: $51.0K2017: $40.0K2018: $28.0K2019: $145.0K2020: $240.0K2021: $52.0K2022: $74.0K2023: $118.0K2024: $8.0K2025: $12.0K$12.0K
2010Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$12.0K+50.0%
2024$8.0K-93.2%
2023$118.0K+59.5%
2022$74.0K+42.3%
2021$52.0K-78.3%
2020$240.0K+65.5%
2019$145.0K+417.9%
2018$28.0K-30.0%
2017$40.0K-21.6%
2016$51.0K-85.0%
2015$339.0K+6680.0%
2014$5.0K+25.0%
2013$4.0K-97.4%
2012$152.1K-73.6%
2011$575.4K+60.9%
2010$357.6K—